{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:37:08Z","timestamp":1787765828774,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03411-8","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:47:11Z","timestamp":1764686831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Global, regional, and national burdens of non-rheumatic calcific aortic valve disease in middle-aged and elderly populations from 1990 to 2021 and predictions up to 2050: trends, predictions, and health inequity"],"prefix":"10.1186","volume":"30","author":[{"given":"Jinlin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanmou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"5","key":"3411_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacc.2015.05.066","volume":"66","author":"TA Pawade","year":"2015","unstructured":"Pawade TA, Newby DE, Dweck MR. Calcification in aortic stenosis: the skeleton key. J Am Coll Cardiol. 2015;66(5):561\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3411_CR2","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","volume":"34","author":"KE Yutzey","year":"2014","unstructured":"Yutzey KE, Demer LL, Body SC, Huggins GS, Towler DA, Giachelli CM, et al. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Arterioscler Thromb Vasc Biol. 2014;34(11):2387\u201393.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3411_CR3","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","volume":"77","author":"M Writing Committee","year":"2021","unstructured":"Writing Committee M, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):e25\u2013197.","journal-title":"J Am Coll Cardiol"},{"key":"3411_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf194","author":"F Praz","year":"2025","unstructured":"Praz F, Borger MA, Lanz J, Marin-Cuartas M, Abreu A, Adamo M, et al. ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf194.","journal-title":"Eur Heart J"},{"issue":"8","key":"3411_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11886-021-01525-z","volume":"23","author":"KB Abeln","year":"2021","unstructured":"Abeln KB, Giebels C, Ehrlich T, Federspiel JM, Schafers HJ. Which aortic valve can be surgically reconstructed? Curr Cardiol Rep. 2021;23(8):108.","journal-title":"Curr Cardiol Rep"},{"key":"3411_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ahj.2023.11.019","volume":"268","author":"P Genereux","year":"2024","unstructured":"Genereux P, Schwartz A, Oldemeyer B, Cohen DJ, Redfors B, Prince H, et al. Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: the EARLY TAVR trial. Am Heart J. 2024;268:94\u2013103.","journal-title":"Am Heart J"},{"issue":"21","key":"3411_CR7","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJMoa2307447","volume":"389","author":"MJ Mack","year":"2023","unstructured":"Mack MJ, Leon MB, Thourani VH, Pibarot P, Hahn RT, Genereux P, et al. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med. 2023;389(21):1949\u201360.","journal-title":"N Engl J Med"},{"issue":"9","key":"3411_CR8","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jcin.2019.12.026","volume":"13","author":"M Abdel-Wahab","year":"2020","unstructured":"Abdel-Wahab M, Landt M, Neumann FJ, Massberg S, Frerker C, Kurz T, et al. 5\u00a0year outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial. JACC Cardiovasc Interv. 2020;13(9):1071\u201382.","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"3411_CR9","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.122.062481","volume":"147","author":"BZ Galper","year":"2023","unstructured":"Galper BZ, Chinnakondepalli KM, Wang K, Magnuson EA, Lu M, Thourani VH, et al. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial. Circulation. 2023;147(21):1594\u2013605.","journal-title":"Circulation"},{"issue":"2","key":"3411_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.14797\/mdcj-8-2-26","volume":"8","author":"MJ Reardon","year":"2012","unstructured":"Reardon MJ. Cost-effectiveness analysis of TAVR. Methodist Debakey Cardiovasc J. 2012;8(2):26\u20138.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"1","key":"3411_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13019-024-03269-7","volume":"20","author":"A Ahmed","year":"2025","unstructured":"Ahmed A, Aziz TAA, AlAsaad MMR, Majthoob M, Altahmody KA. Early and late clinical outcomes and cost-effectiveness of aortic valve replacement using the Inspiris Resilia bioprosthesis\u202f: a systematic review and meta-analysis. J Cardiothorac Surg. 2025;20(1):117.","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"3411_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2432-8","volume":"17","author":"K Kaier","year":"2017","unstructured":"Kaier K, von Kampen F, Baumbach H, von Zur Muhlen C, Hehn P, Vach W, et al. Two-year post-discharge costs of care among patients treated with transcatheter or surgical aortic valve replacement in Germany. BMC Health Serv Res. 2017;17(1):473.","journal-title":"BMC Health Serv Res"},{"key":"3411_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100864","volume":"36","author":"MA Fliegner","year":"2021","unstructured":"Fliegner MA, Sukul D, Thompson MP, Shah NJ, Soroushmehr R, McCullough JS, et al. Evaluating treatment-specific post-discharge quality-of-life and cost-effectiveness of TAVR and SAVR: current practice & future directions. IJC Heart Vasc. 2021;36:100864.","journal-title":"IJC Heart Vasc"},{"issue":"1","key":"3411_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/07853890.2016.1231933","volume":"49","author":"T Peltonen","year":"2017","unstructured":"Peltonen T, Ohukainen P, Ruskoaho H, Rysa J. Targeting vasoactive peptides for managing calcific aortic valve disease. Ann Med. 2017;49(1):63\u201374.","journal-title":"Ann Med"},{"issue":"1","key":"3411_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41467-024-44726-0","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Ren T, Xie L, Hu H, Li X, Maitusong M, et al. Enhancing aortic valve drug delivery with PAR2-targeting magnetic nano-cargoes for calcification alleviation. Nat Commun. 2024;15(1):557.","journal-title":"Nat Commun"},{"issue":"10159","key":"3411_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"Collaborators GBDCoD","year":"2018","unstructured":"Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736\u201388.","journal-title":"Lancet"},{"issue":"10100","key":"3411_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"Collaborators GBDCoD","year":"2017","unstructured":"Collaborators GBDCoD. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151\u2013210.","journal-title":"Lancet"},{"issue":"10062","key":"3411_CR18","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388(10062):e19\u201323.","journal-title":"Lancet"},{"issue":"10159","key":"3411_CR19","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"GBD DALYs","year":"2018","unstructured":"DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859\u2013922.","journal-title":"Lancet"},{"issue":"3","key":"3411_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567\u201381.","journal-title":"Kidney Int"},{"issue":"8","key":"3411_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","volume":"20","author":"LM Moncla","year":"2023","unstructured":"Moncla LM, Briend M, Bosse Y, Mathieu P. Calcific aortic valve disease: mechanisms, prevention and treatment. Nat Rev Cardiol. 2023;20(8):546\u201359.","journal-title":"Nat Rev Cardiol"},{"key":"3411_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2022.06.003","volume":"355","author":"E Boakye","year":"2022","unstructured":"Boakye E, Dardari Z, Obisesan OH, Osei AD, Wang FM, Honda Y, et al. Sex-and race-specific burden of aortic valve calcification among older adults without overt coronary heart disease: the Atherosclerosis Risk in Communities Study. Atherosclerosis. 2022;355:68\u201375.","journal-title":"Atherosclerosis"},{"issue":"6","key":"3411_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2310\/6650.2007.00010","volume":"55","author":"KD O'Brien","year":"2007","unstructured":"O\u2019Brien KD. Epidemiology and genetics of calcific aortic valve disease. J Investig Med. 2007;55(6):284\u201391.","journal-title":"J Investig Med"},{"issue":"1","key":"3411_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12877-025-06095-1","volume":"25","author":"QF Chen","year":"2025","unstructured":"Chen QF, Ni C, Jiang Y, Chen L, Liao H, Gao J, et al. Global burden of disease and its risk factors for adults aged 70 and older across 204 countries and territories: a comprehensive analysis of the Global Burden of Disease Study 2021. BMC Geriatr. 2025;25(1):462.","journal-title":"BMC Geriatr"},{"issue":"5","key":"3411_CR25","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/hec.4651","volume":"32","author":"A Akhtar","year":"2023","unstructured":"Akhtar A, Roy CI. The socioeconomic inequity in healthcare utilization among individuals with cardiovascular diseases in India. Health Econ. 2023;32(5):1000\u201318.","journal-title":"Health Econ"},{"key":"3411_CR26","doi-asserted-by":"publisher","first-page":"1322574","DOI":"10.3389\/fpubh.2024.1322574","volume":"12","author":"B Hu","year":"2024","unstructured":"Hu B, Feng J, Wang Y, Hou L, Fan Y. Transnational inequities in cardiovascular diseases from 1990 to 2019: exploration based on the global burden of disease study 2019. Front Public Health. 2024;12:1322574.","journal-title":"Front Public Health"},{"issue":"3","key":"3411_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.suc.2022.01.008","volume":"102","author":"AS Peters","year":"2022","unstructured":"Peters AS, Duggan JP, Trachiotis GD, Antevil JL. Epidemiology of valvular heart disease. Surg Clin North Am. 2022;102(3):517\u201328.","journal-title":"Surg Clin North Am"},{"issue":"8","key":"3411_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/02184923231200695","volume":"31","author":"K Wang","year":"2023","unstructured":"Wang K, Geng B, Shen Q, Wang Y, Shi J, Dong N. Global, regional, and national incidence, mortality, and disability-adjusted life years of non-rheumatic valvular heart disease and trend analysis from 1990 to 2019: results from the Global Burden of Disease study 2019. Asian Cardiovasc Thorac Ann. 2023;31(8):706\u201322.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"3411_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226733","author":"C Yang","year":"2022","unstructured":"Yang C, Xu H, Jia R, Jin Z, Zhang C, Yuan J. Global burden and improvement gap of non-rheumatic calcific aortic valve disease: 1990\u20132019 findings from global burden of disease study 2019. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11226733.","journal-title":"J Clin Med"},{"key":"3411_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165620","author":"VI Summerhill","year":"2020","unstructured":"Summerhill VI, Moschetta D, Orekhov AN, Poggio P, Myasoedova VA. Sex-specific features of calcific aortic valve disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21165620.","journal-title":"Int J Mol Sci"},{"issue":"10025","key":"3411_CR31","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(16)00586-9","volume":"387","author":"RO Bonow","year":"2016","unstructured":"Bonow RO, Leon MB, Doshi D, Moat N. Management strategies and future challenges for aortic valve disease. Lancet. 2016;387(10025):1312\u201323.","journal-title":"Lancet"},{"issue":"2","key":"3411_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/DCC.0000000000000023","volume":"33","author":"AM Panos","year":"2014","unstructured":"Panos AM, George EL. Transcatheter aortic valve implantation options for treating severe aortic stenosis in the elderly: the nurse\u2019s role in postoperative monitoring and treatment. Dimens Crit Care Nurs. 2014;33(2):49\u201356.","journal-title":"Dimens Crit Care Nurs"},{"issue":"8 Pt 2","key":"3411_CR33","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jchf.2023.07.003","volume":"11","author":"N Okumus","year":"2023","unstructured":"Okumus N, Abraham S, Puri R, Tang WHW. Aortic valve disease, transcatheter aortic valve replacement, and the heart failure patient: a state-of-the-art review. JACC Heart Fail. 2023;11(8 Pt 2):1070\u201383.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"3411_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.acvd.2012.01.005","volume":"105","author":"A Cribier","year":"2012","unstructured":"Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105(3):146\u201352.","journal-title":"Arch Cardiovasc Dis"},{"issue":"1099","key":"3411_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/postgradmedj-2016-134554","volume":"93","author":"S Metaxa","year":"2017","unstructured":"Metaxa S, Ioannou A, Missouris CG. Transcatheter aortic valve implantation: new hope in the management of valvular heart disease. Postgrad Med J. 2017;93(1099):280\u20138.","journal-title":"Postgrad Med J"},{"issue":"11","key":"3411_CR36","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.4244\/EIJ-D-18-01052","volume":"15","author":"J Scherman","year":"2019","unstructured":"Scherman J, Ofoegbu C, Myburgh A, Swanevelder J, van Breda B, Appa H, et al. Preclinical evaluation of a transcatheter aortic valve replacement system for patients with rheumatic heart disease. EuroIntervention. 2019;15(11):e975\u201382.","journal-title":"EuroIntervention"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03411-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03411-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03411-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:47:11Z","timestamp":1764686831000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03411-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3411"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03411-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1206"}}